GLA:D® program outcomes — what the registry data actually shows
The GLA:D® registry now holds outcome data from thousands of participants. Here's what the aggregated evidence shows — and what it means for referral practice.
Since its development in Denmark, GLA:D® (Good Life with osteoArthritis: Denmark) has been implemented internationally with an embedded outcomes registry. For referring clinicians, that registry is a useful evidence base — it reflects real-world delivery rather than tightly controlled trial conditions. This piece summarises what the data shows and how it informs referral decisions.
What GLA:D® is, briefly
GLA:D® is a structured program for hip and knee osteoarthritis combining patient education with supervised, individualised neuromuscular exercise, typically delivered over around six weeks. It's designed to translate first-line OA guideline recommendations — education, exercise, and self-management — into a consistent, deliverable format.
The outcome domains tracked
The registry captures several patient-reported and performance-based measures, typically at baseline, post-program, and follow-up:
- Pain — commonly via a visual analogue scale
- Function — performance-based tests and patient-reported function
- Quality of life and global perceived effect
- Medication use and willingness to undergo surgery
- Physical activity levels
What the data shows
Drawing on the GLA:D® Australia Annual Report 2023, aggregated registry data has indicated the following at twelve-month follow-up:
- Average pain reductions of around 23% (hip) and 31% (knee)
- Improved quality of life — around 24% (hip) and 38% (knee)
- Reduced reliance on pain medication — around 46% (hip) and 50% (knee)
- A reduction in the proportion of participants reporting a wish for surgery after completing the program
Registry outcomes reflect real-world delivery and aren't controlled against a comparator. They're best read as evidence of program effectiveness in practice, complementing — not replacing — RCT-level evidence for exercise and education in OA.
Implications for referral practice
For GPs and orthopaedic colleagues, the practical relevance is in timing and expectation-setting:
- Refer early. GLA:D® is a first-line intervention, appropriate well before surgical conversations — not a last resort after other options are exhausted.
- Frame realistically. It's an active program requiring participation; outcomes track with engagement. Patients who understand this upfront tend to do better.
- Surgery isn't precluded. For patients heading toward joint replacement, completing the program first can improve pre-operative conditioning, and some patients improve enough to defer.
The bottom line
The registry supports what guideline bodies already recommend: structured education and exercise should be offered to people with hip and knee OA as a matter of course. GLA:D® provides a consistent vehicle for delivering it. For referring clinicians, the main shift is to think of it early in the pathway rather than late.
Happy to discuss specific patients or the referral process directly — see the contact options below.
References
- 1. GLA:D® Australia Annual Report 2023. La Trobe University, Melbourne. [Link]
- 2. Roos EM, Grønne DT, Skou ST, et al. Immediate outcomes following the GLA:D® program in Denmark, Canada and Australia. A longitudinal analysis including 28,370 patients with symptomatic knee or hip osteoarthritis. Osteoarthritis and Cartilage. 2021;29(4):502–510. [Link]
- 3. Barton CJ, Kemp JL, Roos EM, et al. Program evaluation of GLA:D® Australia: physiotherapist and patient outcomes. Osteoarthritis and Cartilage. 2021;29(8):1154–1164. [Link]
- 4. Bell J, Barton CJ, et al. Association of baseline physical activity participation with participant characteristics and outcomes following education and exercise-therapy in people with knee osteoarthritis: A GLA:D® Australia prospective cohort study. Musculoskeletal Care. 2023;21(4). [Link]
- 5. Royal Australian College of General Practitioners. Guideline for the management of knee and hip osteoarthritis. 2nd ed. East Melbourne: RACGP; 2018. [Link]
This article provides general educational information and does not constitute individual medical advice. It is not a substitute for assessment by a qualified health professional. Always seek advice tailored to your specific circumstances from your treating practitioner.
Emil Terbio
Physiotherapist · APA Member · GLA:D® Certified Clinician · AHPRA registered
Emil is a Canberra-based physiotherapist with a special interest in osteoarthritis, inflammatory arthritis, and balance & vestibular conditions. He runs Filophys as a mobile, in-clinic, and telehealth practice — built around honest care, evidence-based treatment, and patient education.
Related articles
Spondyloarthropathy physiotherapy — where the evidence sits in 2026
Vestibular rehab referral — what to look for before you send
Central sensitisation in chronic pain — clinical implications for referrals
Have a patient who might benefit?
Whether you'd like to refer a patient or discuss a case clinician-to-clinician, Emil reads every message personally. Flag your enquiry and he'll respond directly.